Minimal Disease Activity and Remission in Psoriatic Arthritis Patients Treated with Anti-TNF-α Drugs.

CONCLUSION: In our prospective observational study, based on a clinical practice setting, MDA was achieved in 61.3% of patients treated with TNF-α blockers, identifying this as an achievable target for patients with PsA. Predictors of remission were also identified. PMID: 26669925 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/26669925?dopt=Abstract

Source: J Rheumatol - December 15, 2015 Category: Rheumatology Authors: Perrotta FM, Marchesoni A, Lubrano E Tags: J Rheumatol Source Type: research